Does Ibrutinib impact outcomes of viral infection by SARS-CoV-2 in mantle cell lymphoma patients?

Curr Res Transl Med. 2021 Jan;69(1):103273. doi: 10.1016/j.retram.2020.103273. Epub 2020 Nov 25.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenine / adverse effects
  • Adenine / analogs & derivatives*
  • Adenine / therapeutic use
  • Agammaglobulinaemia Tyrosine Kinase / antagonists & inhibitors
  • Aged
  • COVID-19 / epidemiology*
  • Comorbidity
  • Humans
  • Lymphoma, Mantle-Cell / drug therapy*
  • Lymphoma, Mantle-Cell / epidemiology*
  • Male
  • Piperidines / adverse effects*
  • Piperidines / therapeutic use*
  • SARS-CoV-2*

Substances

  • Piperidines
  • ibrutinib
  • Agammaglobulinaemia Tyrosine Kinase
  • Adenine